Biotech firms tests cell therapy for cancer – The Columbian
The Columbian |
Biotech firms tests cell therapy for cancer
The Columbian CAR–T cell therapy for aggressive B cell Non-Hodgkin lymphoma, the form of cancer Symes had, is the most promising product in the pipeline of Seattle-based biotech company Juno Therapeutics. Many oncologists expect CAR–T cell therapies to completely … |
